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A 58-year-old male shop keeper presented with asymptom-atic hypochromic microcytic anemia in August 2007. He
admitted to heavy alcohol consumption and 40 pack years of
smoking. A year later, he presented to an emergency room
with shortness of breath and tachycardia and was admitted to
hospital. Electrocardiography was noncontributing. Further
cardiac evaluation showed a pericardial effusion and an 8.8
cm 6.4 cm 6.6-cm cardiac mass immediately adjacent to
the lower esophagus involving the pericardium, left atrium,
inferior left ventricle, interatrial septum, circumflex coronary
artery, and inferior vena cava (Figure 1). Ejection fraction
was 49%.
A jugular transvenous biopsy demonstrated central ne-
crosis with hyperchromatic and pleomorphic polygonal cells
disposed singly and in loose aggregates (Figure 2). Immuno-
staining was positive for CD31 and CD34 and negative for
S-100, human melanoma black-45, CD45, CD20, thyroid
transcription factor-1, and calretinin consistent with primary
cardiac angiosarcoma. The tumor was determined to be
inoperable.
Based on the report of Nakamura-Horigome et al.,1 the
patient was treated with concomitant chemoradiotherapy con-
sisting of 3D conformal radiation and docetaxel at a dose of
25 mg/m2 weekly during radiation and up to 7 months after.
Magnetic resonance imaging in December 2008 showed a
partial response, which was unchanged 4 months later (Fig-
ure 3). Chemotherapy continued until June 2009. In Septem-
ber 2009, he developed shortness of breath and presented
with a left pleural effusion. Cytology was negative. Imaging
suggested no progression of his tumor, but he required a
continuous pleural drainage catheter to remain at home. In
March 2010, he was readmitted for worsening shortness of
breath. He died 2 weeks later, 16 months after completing
radiotherapy. His tumor mass was radiologically stable.
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FIGURE 1. Multislice magnetic resonance imaging of
heart during initial workup in August 2008. An 8.8 cm 
6.4 cm  6.6-cm mass affecting primarily the left atrium,
with extension into the right atrium at the interatrial sep-
tum is demonstrated (arrow). Inferiorly, there is involve-
ment of the left ventricle, inferior vena cava, and the mass
is intimate to the lower esophagus and abuts, the anterior
aspect of the descending aorta.
FIGURE 2. Histopathology demonstrates high-cellular, par-
tially necrotic tissue composed of hyperchromatic and pleo-
morphic polygonal cells singly and in loose aggregates.
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In adults, angiosarcoma is the most common type of
cardiac sarcoma but is still rare and metastatic tumors to the
heart occur far more often.2 Presentation is usually late, and
most are unresectable.3 Treatment has been pursued in an ad
hoc manner with surgery, chemotherapy, and radiotherapy,
all playing roles without the benefit of clinical trials.4
A recent case report from Japan noted a durable re-
sponse of 12 months using radiation with concomitant and
then maintenance docetaxel. By using the same, we observed
a partial response followed by progression-free survival for
16 months. The literature suggests survival in the range of 4
to 5 months for patients with extensive unresectable disease.5
The patient was dependent on chest tubes to drain
pleural effusions for his last several months. The pleural
effusions were not clearly related to his tumor. We were not
able to ascertain to what degree his final symptoms were
related to radiation-related damage to the lungs, heart, or
pericardium. It is possible that chronic pericardial changes
from radiation may have contributed, but radiation-induced
pericardial changes would be obscured on computed tomog-
raphy by pericardial tumor involvement and pleural effusion.
By using chemoradiotherapy, we were able to obtain a doc-
umented partial response and a prolonged course of stable
disease for 16 months including a return to work for 11
months. This regimen deserves further investigation.
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Erratum
Correlation of IHC and FISH for ALK Gene Rearrangement in Non-small Cell Lung Carcinoma: IHC Score Algorithm for FISH: Erratum
In the article that appeared on page 459 of the March issue, Figure 2 included an identifying number in the top right corner which should have been
removed. The corrected figure appears below. This error has been noted in the online version of the article, which is available at www.jto.org.
Reference:
Yi ES, Boland JM, Maleszewski JJ, et al. Correlation of IHC and FISH for ALK Gene Rearrangement in Non-small Cell Lung Carcinoma: IHC Score
Algorithm for FISH. J Thorac Oncol. 2011;6:459–465.
FIGURE 3. Magnetic resonance imaging on follow-up in
February 2009, 4 months after completing radiation therapy.
A decrease in tumor size is noted, 5.2 cm  4.2 cm.
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